TOP NEWS

OncoSec Raises $7.5M In PIPE

San Diego-based OncoSec Medical said Tuesday that it has raised $7.5M in a registered direct offering, with un-named, institutional investors. The publicly traded company, which trades on the NASDAQ as ONCS, develops cancer immunotherapy products. OncoSec said it sold 2,142,860 shares of its common stock at a price of $3.50 per share to those investors, plus warrants for 1,071,430 shares of common stock at $4.50 per share for the next 5.5 years. The company said the new funds will go towards general corporate purposes, including clinical trial expenses and research and development expenses.


LATEST HEADLINES

More Headlines

BROWSE ISSUES